Q2 2019 Allogene Therapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and thank you for standing by, and welcome to Allogene Therapeutics' Second Quarter 2019 Conference Call. (Operator Instructions) Please be aware that today's conference call is being recorded.
I would now like to turn the conference over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.
Thank you, operator, and good morning. Before market opened today, Allogene issued a press release that provides a corporate update and financial results for the quarter ended June 30, 2019. The press release is available on our website at www.allogene.com. We will be discussing our ALLO-715 Phase I clinical trial protocol today and I've posted on our website a slide, which provides an overview of the trial. This can be found in the Investors section under news and events. We remind listeners that today's call is being webcast on our website and will be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |